Applera has named George Adam to its board of directors. The firm said the board now has 11 members, and that it expects several to retire over the next few years. The company said it also may need extra directors in the event that it decides to separate its Applied Biosystems and Celera businesses into two distinct groups, an option it has been considering since August.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.